The 2018 Winter Olympics will end soon, and we did not skate through these games without a performance-enhancing drug allegation rearing its ugly head.
In late 2015, the National Science Foundation awarded a $6 million grant to the non-profit organization U.S. Ignite to help drive the development of next-generation “gigabit applications,” as part of a broader effort to create “smart gigabit communities” throughout the U.S.... Read more »
Kallyope is unusual among biotech startups. Exclusively borne from the work of three Columbia University professors, the company started up in Manhattan, now has more than 40 employees, has gotten $110 million in venture dollars from high-profile investors, and still... Read more »
When we last caught up with Dan Belcher and Izzy Azeri, they were selling their cloud-management company, Stackdriver, to Google. That Boston startup was on a fast track to acquisition, getting scooped up in 2014 after just two years and... Read more »
The immuno-oncology combination frenzy continues. Merck this morning agreed to pay $394 million for Viralytics, an Australian developer of oncolytic viruses, which could help boost the power of the pharma giant’s cancer immunotherapy pembrolizumab (Keytruda).
Silvio Micali says he mistimed his first two technology startups. But the renowned MIT professor thinks he’s hitting the market at the right moment with his latest company, Algorand, which plans to launch a blockchain-based virtual currency and transactions system this... Read more »
Critical communications software company Everbridge has made a $33.6 million cash bid to acquire Norwegian competitor Unified Messaging Systems (UMS) in a deal that would grow its overseas presence.
Tetraphase Pharmaceuticals’ ups and downs have continued, as new data have clouded the future of the Watertown, MA, company’s experimental antibiotic, eravacycline, once again.
Tetraphase (NASDAQ: TTPH) reported that eravacycline failed a 1,200-patient Phase 3 study called Ignite3, one... Read more »
Carbonite has agreed to buy competing online data backup service Mozy from Dell Technologies for $145.8 million, according to an announcement about the company’s 2017 financial results. Carbonite said the deal expands its customer base and the number of market segments... Read more »
Wearable device maker Fitbit is extending its reach into hospitals and doctors’ offices with the planned acquisition of Twine Health, an MIT spinout that sells healthcare coaching and collaboration software.
CEO, Optum Labs
Founder and International Chairman, Boston Power
Chairman, Entrepreneurship Ventures, Inc.
Co-Founder, G20 Ventures and General Partner, Advanced Technology Ventures
Director of the M.I.T Technology Licensing Office
Strategic Advisor, Innovation and Strategy, Citigroup
Inbound Marketing Evangelist, HubSpot
Professor of Genetics, Harvard Medical School
Professor of Leadership, Emeritus at the Harvard Business School
Partner, Nixon Peabody LLP
CEO and Co-Founder, Tamr